MMP2 and diabetes mellitus: In an experimental model of streptozotocin-induced diabetes mellitus (DM) in rats, elevated oxidative stress biomarkers activated MMP2 expression, whereas pretreatment with epigallocatechin gallate nanopreparations significantly reduced plasma MMP2 levels in DM rats and improved antioxidant defenses in DM rats [73].